Smart Pill Box is projected to lead at 58.0% share in 2026, followed by Diabetes Care as set to secure 22.0% share of indication in 2026. Medication non-adherence costs are expected to push payer-sponsored smart pill device procurement as health systems target avoidable hospitalization reduction. Patient technology acceptance barriers among elderly populations are likely to slow adoption if device complexity and connectivity setup exceed user capability.